Medscape1d
Pharmacokinetics and Safety of Continuously Applied Lidocaine Patches 5%
The pharmacokinetics, safety, and tolerability of four topical lidocaine patches 5% continuously applied for 72 hours and changed every 12 or 24 hours were examined. In this randomized ...
Medscape4d
Contact Allergy to Lidocaine: A Report of Sixteen Cases
We report 16 cases of lidocaine contact allergy seen over 5 years. Concomitant patch-test reactions occurred with neomycin 20% (10 cases), bacitracin 20% (9 cases), fragrance mix 8% (3 cases ...
TMCnet6h
Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
GTX-104 is a clinical stage, novel, injectable formulation of nimodipine being developed for intravenous (IV) infusion in aSAH patients to address significant unmet medical needs. The unique ...
Acasti Pharma, Inc.: Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel injectable formulation of nimodipine ...
verywellhealth5d
What Is Novocaine & How Is It Used?
A novocaine/epinephrine mixture delays absorption and can last for up to 90 minutes. Lidocaine is an amide-based local anesthetic that is more potent and lasts longer than novocaine. Since the 1970s, ...